Showing 1 - 6 results of 6 for search 'Vinod Vathipadiekal', query time: 0.03s Refine Results
  1. 1
    Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer.

    Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer. by Vinod Vathipadiekal, Deepa Saxena, Samuel C Mok, Peter V Hauschka, Laurent Ozbun, Michael J Birrer

    Published 2012-01-01
    Get full text
    Article
  2. 2
    An RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancer.

    An RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancer. by Geetika Sethi, Harsh B Pathak, Hong Zhang, Yan Zhou, Margret B Einarson, Vinod Vathipadiekal, Sumedha Gunewardena, Michael J Birrer, Andrew K Godwin

    Published 2012-01-01
    Get full text
    Article
  3. 3
    CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis.

    CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis. by Amanda Sosulski, Heiko Horn, Lihua Zhang, Caroline Coletti, Vinod Vathipadiekal, Cesar M Castro, Michael J Birrer, Osamu Nagano, Hideyuki Saya, Kasper Lage, Patricia K Donahoe, David Pépin

    Published 2016-01-01
    Get full text
    Article
  4. 4
    Inhibition of Hedgehog signaling antagonizes serous ovarian cancer growth in a primary xenograft model.

    Inhibition of Hedgehog signaling antagonizes serous ovarian cancer growth in a primary xenograft model. by Christopher K McCann, Whitfield B Growdon, Kashmira Kulkarni-Datar, Michael D Curley, Anne M Friel, Jennifer L Proctor, Hana Sheikh, Igor Deyneko, Jeanne A Ferguson, Vinod Vathipadiekal, Michael J Birrer, Darrell R Borger, Gayatry Mohapatra, Lawrence R Zukerberg, Rosemary Foster, John R Macdougall, Bo R Rueda

    Published 2011-01-01
    Get full text
    Article
  5. 5
    Identification of novel therapeutic targets in microdissected clear cell ovarian cancers.

    Identification of novel therapeutic targets in microdissected clear cell ovarian cancers. by Michael P Stany, Vinod Vathipadiekal, Laurent Ozbun, Rebecca L Stone, Samuel C Mok, Hui Xue, Takashi Kagami, Yuwei Wang, Jessica N McAlpine, David Bowtell, Peter W Gout, Dianne M Miller, C Blake Gilks, David G Huntsman, Susan L Ellard, Yu-Zhuo Wang, Pablo Vivas-Mejia, Gabriel Lopez-Berestein, Anil K Sood, Michael J Birrer

    Published 2011-01-01
    Get full text
    Article
  6. 6
    Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L

    Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L by Christopher J. LaFargue, Paola Amero, Kyunghee Noh, Lingegowda S. Mangala, Yunfei Wen, Emine Bayraktar, Sujanitha Umamaheswaran, Elaine Stur, Santosh K. Dasari, Cristina Ivan, Sunila Pradeep, Wonbeak Yoo, Chunhua Lu, Nicholas B. Jennings, Vinod Vathipadiekal, Wei Hu, Anca Chelariu-Raicu, Zhiqiang Ku, Hui Deng, Wei Xiong, Hyun-Jin Choi, Min Hu, Takae Kiyama, Chai-An Mao, Rouba Ali-Fehmi, Michael J. Birrer, Jinsong Liu, Ningyan Zhang, Gabriel Lopez-Berestein, Vittorio de Franciscis, Zhiqiang An, Anil K. Sood

    Published 2023-04-01
    Get full text
    Article

Search Tools: